Broadening the phenotype and genotype spectrum of novel mutations in pontocerebellar hypoplasia with a comprehensive molecular literature review.
Novel clinical findings
Novel mutations
PCH
Pontocerebellar Hypoplasia
WES
Whole exome sequencing
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
13 Feb 2024
13 Feb 2024
Historique:
received:
26
04
2023
accepted:
16
01
2024
medline:
13
2
2024
pubmed:
13
2
2024
entrez:
12
2
2024
Statut:
epublish
Résumé
Pontocerebellar hypoplasia is an umbrella term describing a heterogeneous group of prenatal neurodegenerative disorders mostly affecting the pons and cerebellum, with 17 types associated with 25 genes. However, some types of PCH lack sufficient information, which highlights the importance of investigating and introducing more cases to further elucidate the clinical, radiological, and biochemical features of these disorders. The aim of this study is to provide an in-depth review of PCH and to identify disease genes and their inheritance patterns in 12 distinct Iranian families with clinically confirmed PCH. Cases included in this study were selected based on their phenotypic and genetic information available at the Center for Comprehensive Genetic Services. Whole-exome sequencing (WES) was used to discover the underlying genetic etiology of participants' problems, and Sanger sequencing was utilized to confirm any suspected alterations. We also conducted a comprehensive molecular literature review to outline the genetic features of the various subtypes of PCH. This study classified and described the underlying etiology of PCH into three categories based on the genes involved. Twelve patients also were included, eleven of whom were from consanguineous parents. Ten different variations in 8 genes were found, all of which related to different types of PCH. Six novel variations were reported, including SEPSECS, TSEN2, TSEN54, AMPD2, TOE1, and CLP1. Almost all patients presented with developmental delay, hypotonia, seizure, and microcephaly being common features. Strabismus and elevation in lactate levels in MR spectroscopy were novel phenotypes for the first time in PCH types 7 and 9. This study merges previously documented phenotypes and genotypes with unique novel ones. Due to the diversity in PCH, we provided guidance for detecting and diagnosing these heterogeneous groups of disorders. Moreover, since certain critical conditions, such as spinal muscular atrophy, can be a differential diagnosis, providing cases with novel variations and clinical findings could further expand the genetic and clinical spectrum of these diseases and help in better diagnosis. Therefore, six novel genetic variants and novel clinical and paraclinical findings have been reported for the first time. Further studies are needed to elucidate the underlying mechanisms and potential therapeutic targets for PCH.
Sections du résumé
BACKGROUND
BACKGROUND
Pontocerebellar hypoplasia is an umbrella term describing a heterogeneous group of prenatal neurodegenerative disorders mostly affecting the pons and cerebellum, with 17 types associated with 25 genes. However, some types of PCH lack sufficient information, which highlights the importance of investigating and introducing more cases to further elucidate the clinical, radiological, and biochemical features of these disorders. The aim of this study is to provide an in-depth review of PCH and to identify disease genes and their inheritance patterns in 12 distinct Iranian families with clinically confirmed PCH.
METHODS
METHODS
Cases included in this study were selected based on their phenotypic and genetic information available at the Center for Comprehensive Genetic Services. Whole-exome sequencing (WES) was used to discover the underlying genetic etiology of participants' problems, and Sanger sequencing was utilized to confirm any suspected alterations. We also conducted a comprehensive molecular literature review to outline the genetic features of the various subtypes of PCH.
RESULTS
RESULTS
This study classified and described the underlying etiology of PCH into three categories based on the genes involved. Twelve patients also were included, eleven of whom were from consanguineous parents. Ten different variations in 8 genes were found, all of which related to different types of PCH. Six novel variations were reported, including SEPSECS, TSEN2, TSEN54, AMPD2, TOE1, and CLP1. Almost all patients presented with developmental delay, hypotonia, seizure, and microcephaly being common features. Strabismus and elevation in lactate levels in MR spectroscopy were novel phenotypes for the first time in PCH types 7 and 9.
CONCLUSIONS
CONCLUSIONS
This study merges previously documented phenotypes and genotypes with unique novel ones. Due to the diversity in PCH, we provided guidance for detecting and diagnosing these heterogeneous groups of disorders. Moreover, since certain critical conditions, such as spinal muscular atrophy, can be a differential diagnosis, providing cases with novel variations and clinical findings could further expand the genetic and clinical spectrum of these diseases and help in better diagnosis. Therefore, six novel genetic variants and novel clinical and paraclinical findings have been reported for the first time. Further studies are needed to elucidate the underlying mechanisms and potential therapeutic targets for PCH.
Identifiants
pubmed: 38347586
doi: 10.1186/s12920-024-01810-0
pii: 10.1186/s12920-024-01810-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
51Informations de copyright
© 2024. The Author(s).
Références
Barth PG. Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev. 1993;15(6):411–22.
pubmed: 8147499
doi: 10.1016/0387-7604(93)90080-R
Mochida GH, Ganesh VS, de Michelena MI, Dias H, Atabay KD, Kathrein KL, et al. CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development. Nat Genet. 2012;44(11):1260–4.
pubmed: 23023333
pmcid: 3567443
doi: 10.1038/ng.2425
Karaca E, Weitzer S, Pehlivan D, Shiraishi H, Gogakos T, Hanada T, et al. Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell. 2014;157(3):636–50.
pubmed: 24766809
pmcid: 4146440
doi: 10.1016/j.cell.2014.02.058
Schaffer AE, Eggens VRC, Caglayan AO, Reuter MS, Scott E, Coufal NG, et al. CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration. Cell. 2014;157(3):651–63.
pubmed: 24766810
pmcid: 4128918
doi: 10.1016/j.cell.2014.03.049
Wafik M, Taylor J, Lester T, Gibbons RJ, Shears DJ. 2 new cases of pontocerebellar hypoplasia type 10 identified by whole exome sequencing in a Turkish family. Eur J Med Genet. 2018;61:273–9. Netherlands.
pubmed: 29307788
doi: 10.1016/j.ejmg.2018.01.002
van Dijk T, Baas F, Barth PG, Poll-The BT. What’s new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet J Rare Dis. 2018;13(1):92.
pubmed: 29903031
pmcid: 6003036
doi: 10.1186/s13023-018-0826-2
Appelhof B, Wagner M, Hoefele J, Heinze A, Roser T, Koch-Hogrebe M, et al. Pontocerebellar hypoplasia due to bi-allelic variants in MINPP1. Eur J Hum Genet. 2021;29(3):411–21.
pubmed: 33168985
doi: 10.1038/s41431-020-00749-x
Chai G, Webb A, Li C, Antaki D, Lee S, Breuss MW, et al. Mutations in spliceosomal genes PPIL1 and PRP17 cause neurodegenerative pontocerebellar hypoplasia with microcephaly. Neuron. 2021;109(2):241-256.e9.
pubmed: 33220177
doi: 10.1016/j.neuron.2020.10.035
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589–95.
pubmed: 20080505
pmcid: 2828108
doi: 10.1093/bioinformatics/btp698
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25(16):2078–9.
pubmed: 19505943
pmcid: 2723002
doi: 10.1093/bioinformatics/btp352
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.
pubmed: 20644199
pmcid: 2928508
doi: 10.1101/gr.107524.110
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–42.
pubmed: 10592235
pmcid: 102472
doi: 10.1093/nar/28.1.235
Gerlach P, Schuller JM, Bonneau F, Basquin J, Reichelt P, Falk S, et al. Distinct and evolutionary conserved structural features of the human nuclear exosome complex. Elife. 2018;7:e38686.
pubmed: 30047866
pmcid: 6072439
doi: 10.7554/eLife.38686
Hayne CK, Butay KJU, Stewart ZD, Krahn JM, Perera L, Williams JG, Petrovitch RM, Deterding LJ, Matera AG, Borgnia MJ, Stanley RE. Structural basis for pre-tRNA recognition and processing by the human tRNA splicing endonuclease complex. Nat Struct Mol Biol. 2023;1545-9993:1–10.
Puppala AK, Castillo Suchkou J, French RL, Kiernan KA, Simonović M. Structural basis for the tRNA-dependent activation of the terminal complex of selenocysteine synthesis in humans. Nucleic Acids Res. 2023;51(8):4012–26.
Kitao Y, Saito T, Watanabe S, Ohe Y, Takahashi K, Akaki T, et al. The discovery of 3, 3-dimethyl-1, 2, 3, 4-tetrahydroquinoxaline-1-carboxamides as AMPD2 inhibitors with a novel mechanism of action. Bioorg Med Chem Lett. 2023;80:129110.
pubmed: 36563792
doi: 10.1016/j.bmcl.2022.129110
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296-303.
pubmed: 29788355
pmcid: 6030848
doi: 10.1093/nar/gky427
Liu D, Yang F, Liu Z, Wang J, Huang W, Meng W, et al. Structure of TBC1D23 N-terminus reveals a novel role for rhodanese domain. PLoS Biol. 2020;18(5):e3000746.
pubmed: 32453802
pmcid: 7274447
doi: 10.1371/journal.pbio.3000746
Hayne CK, Schmidt CA, Haque MI, Matera AG, Stanley RE. Reconstitution of the human tRNA splicing endonuclease complex: insight into the regulation of pre-tRNA cleavage. Nucleic Acids Res. 2020;48(14):7609–22.
pubmed: 32476018
pmcid: 7641302
doi: 10.1093/nar/gkaa438
Trotta CR, Paushkin SV, Patel M, Li H, Peltz SW. Cleavage of pre-tRNAs by the splicing endonuclease requires a composite active site. Nature. 2006;441(7091):375–7.
pubmed: 16710424
doi: 10.1038/nature04741
Samanta D, Willis E. Intractable epileptic spasms in a patient with Pontocerebellar hypoplasia: Severe phenotype of type 2 or another subtype? Ann Indian Acad Neurol. 2016;19:385–7 India.
pubmed: 27570394
pmcid: 4980965
doi: 10.4103/0972-2327.168629
Budde BS, Namavar Y, Barth PG, Poll-The BT, Nürnberg G, Becker C, et al. tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet. 2008;40(9):1113–8.
pubmed: 18711368
doi: 10.1038/ng.204
Breuss MW, Sultan T, James KN, Rosti RO, Scott E, Musaev D, et al. Autosomal-recessive mutations in the tRNA splicing endonuclease subunit TSEN15 cause pontocerebellar hypoplasia and progressive microcephaly. Am J Hum Genet. 2016;99(3):785.
pubmed: 27588454
pmcid: 5011070
doi: 10.1016/j.ajhg.2016.08.009
van Dijk T, Baas F. TSEN54 Pontocerebellar Hypoplasia. In: GeneReviews®. Seattle, Seattle (WA): University of Washington; 1993.
Tortora M, Spaccini L, Lanna M, Zambon M, Izzo G, Parazzini C, et al. TSEN54 gene-related pontocerebellar-hypoplasia and role of prenatal MR imaging: besides the common posterior fossa cystic malformations. London: Cerebellum; 2022.
Amin M, Vignal C, Hamed AAA, Mohammed IN, Elseed MA, Abubaker R, et al. Case report: a new family with pontocerebellar hypoplasia 10 from Sudan. Front Genet. 2022;13:883211. Switzerland.
pubmed: 35719383
pmcid: 9201487
doi: 10.3389/fgene.2022.883211
Monaghan CE, Adamson SI, Kapur M, Chuang JH, Ackerman SL. The Clp1 R140H mutation alters tRNA metabolism and mRNA 3’ processing in mouse models of pontocerebellar hypoplasia. Proc Natl Acad Sci U S A. 2021;118(39):e2110730118.
pubmed: 34548404
pmcid: 8488643
doi: 10.1073/pnas.2110730118
Sevinç S, İnci A, Ezgü FS, Eminoğlu FT. A patient with a novel RARS2 variant exhibiting liver involvement as a new clinical feature and review of the literature. Mol Syndromol. 2022;13:226–34. Switzerland.
pubmed: 35707589
pmcid: 9149545
doi: 10.1159/000519604
Delagoutte B, Moras D, Cavarelli J. tRNA aminoacylation by arginyl-tRNA synthetase: induced conformations during substrates binding. EMBO J. 2000;19(21):5599–610.
pubmed: 11060012
pmcid: 305789
doi: 10.1093/emboj/19.21.5599
van Dijk T, van Ruissen F, Jaeger B, Rodenburg RJ, Tamminga S, van Maarle M, et al. RARS2 mutations: is pontocerebellar hypoplasia type 6 a mitochondrial encephalopathy? JIMD Rep. 2017;33:87–92.
pubmed: 27683254
doi: 10.1007/8904_2016_584
Agamy O, Ben Zeev B, Lev D, Marcus B, Fine D, Su D, et al. Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy. Am J Hum Genet. 2010;87(4):538–44.
pubmed: 20920667
pmcid: 2948803
doi: 10.1016/j.ajhg.2010.09.007
Makrythanasis P, Nelis M, Santoni FA, Guipponi M, Vannier A, Béna F, et al. Diagnostic exome sequencing to elucidate the genetic basis of likely recessive disorders in consanguineous families. Hum Mutat. 2014;35(10):1203–10.
pubmed: 25044680
doi: 10.1002/humu.22617
Wirth EK, Bharathi BS, Hatfield D, Conrad M, Brielmeier M, Schweizer U. Cerebellar hypoplasia in mice lacking selenoprotein biosynthesis in neurons. Biol Trace Elem Res. 2014;158(2):203–10.
pubmed: 24599700
pmcid: 3984410
doi: 10.1007/s12011-014-9920-z
Anttonen A-K, Hilander T, Linnankivi T, Isohanni P, French RL, Liu Y, et al. Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate. Neurology. 2015;85(4):306–15.
pubmed: 26115735
pmcid: 4520820
doi: 10.1212/WNL.0000000000001787
Ivanov I, Atkinson D, Litvinenko I, Angelova L, Andonova S, Mumdjiev H, et al. Pontocerebellar hypoplasia type 1 for the neuropediatrician: genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2018;22(4):674–81.
doi: 10.1016/j.ejpn.2018.03.011
Morton DJ, Kuiper EG, Jones SK, Leung SW, Corbett AH, Fasken MB. The RNA exosome and RNA exosome-linked disease. RNA. 2018;24(2):127–42.
pubmed: 29093021
pmcid: 5769741
doi: 10.1261/rna.064626.117
Spyridakis AC, Cao Y, Litra F. A rare case of pontocerebellar hypoplasia Type 1B with literature review. Cureus. 2022;14:e27098. United States.
pubmed: 36004024
pmcid: 9392422
Dabaj I, Hassani A, Burglen L, Qebibo L, Guerrot A-M, Marret S, et al. Pontocerebellar hypoplasia type 1D: a case report and comprehensive literature review. J Clin Med. 2022;11:4335. Switzerland.
pubmed: 35893425
pmcid: 9368788
doi: 10.3390/jcm11154335
Somashekar PH, Kaur P, Stephen J, Guleria VS, Kadavigere R, Girisha KM, et al. Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia. Clin Genet. 2021;99(4):594–600.
pubmed: 33463720
pmcid: 9990822
doi: 10.1111/cge.13928
Bilge S, Mert GG, Hergüner Ö, Özcanyüz D, Bozdoğan ST, Kaya Ö, et al. Clinical, radiological, and genetic variation in pontocerebellar hypoplasia disorder and our clinical experience. Ital J Pediatr. 2022;48(1):169.
pubmed: 36076253
pmcid: 9461104
doi: 10.1186/s13052-022-01349-9
Lardelli RM, Schaffer AE, Eggens VRC, Zaki MS, Grainger S, Sathe S, et al. Biallelic mutations in the 3’ exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing. Nat Genet. 2017;49(3):457–64.
pubmed: 28092684
pmcid: 5325768
doi: 10.1038/ng.3762
Son A, Park J-E, Kim VN. PARN and TOE1 Constitute a 3’ end maturation module for nuclear non-coding RNAs. Cell Rep. 2018;23(3):888–98.
pubmed: 29669292
doi: 10.1016/j.celrep.2018.03.089
Deng T, Huang Y, Weng K, Lin S, Li Y, Shi G, et al. TOE1 acts as a 3’ exonuclease for telomerase RNA and regulates telomere maintenance. Nucleic Acids Res. 2019;47(1):391–405.
pubmed: 30371886
doi: 10.1093/nar/gky1019
Vinograd-Byk H, Sapir T, Cantarero L, Lazo PA, Zeligson S, Lev D, et al. The spinal muscular atrophy with pontocerebellar hypoplasia gene VRK1 regulates neuronal migration through an amyloid-β precursor protein-dependent mechanism. J Neurosci Off J Soc Neurosci. 2015;35(3):936–42.
doi: 10.1523/JNEUROSCI.1998-14.2015
Li Q, Madden JA, Lin J, Shi J, Rosen SM, Schmitz-Abe K, et al. Reanalysis of exome data identifies novel SLC25A46 variants associated with leigh syndrome. J Pers Med. 2021;11(12):1277.
pubmed: 34945750
pmcid: 8703603
doi: 10.3390/jpm11121277
Wan J, Steffen J, Yourshaw M, Mamsa H, Andersen E, Rudnik-Schöneborn S, et al. Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia. Brain. 2016;139(11):2877–90.
pubmed: 27543974
pmcid: 5840878
doi: 10.1093/brain/aww212
Palmieri F. The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med. 2013;34(2–3):465–84.
pubmed: 23266187
doi: 10.1016/j.mam.2012.05.005
Haitina T, Lindblom J, Renström T, Fredriksson R. Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics. 2006;88(6):779–90. Available from: https://www.sciencedirect.com/science/article/pii/S0888754306001996 .
pubmed: 16949250
doi: 10.1016/j.ygeno.2006.06.016
Khakurel A, Kudlyk T, Bonifacino JS, Lupashin VV. The Golgi-associated retrograde protein (GARP) complex plays an essential role in the maintenance of the Golgi glycosylation machinery. Mol Biol Cell. 2021;32(17):1594–610.
pubmed: 34161137
pmcid: 8351751
doi: 10.1091/mbc.E21-04-0169
Feinstein M, Flusser H, Lerman-Sagie T, Ben-Zeev B, Lev D, Agamy O, et al. VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2). J Med Genet. 2014;51(5):303–8.
pubmed: 24577744
doi: 10.1136/jmedgenet-2013-101823
Hady-Cohen R, Ben-Pazi H, Adir V, Yosovich K, Blumkin L, Lerman-Sagie T, et al. Progressive cerebello-cerebral atrophy and progressive encephalopathy with edema, hypsarrhythmia and optic atrophy may be allelic syndromes. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2018;22(6):1133–8.
doi: 10.1016/j.ejpn.2018.07.003
Gershlick DC, Ishida M, Jones JR, Bellomo A, Bonifacino JS, Everman DB. A neurodevelopmental disorder caused by mutations in the VPS51 subunit of the GARP and EARP complexes. Hum Mol Genet. 2019;28(9):1548–60.
pubmed: 30624672
pmcid: 6489419
doi: 10.1093/hmg/ddy423
Waites CL, Leal-Ortiz SA, Andlauer TFM, Sigrist SJ, Garner CC. Piccolo regulates the dynamic assembly of presynaptic F-actin. J Neurosci Off J Soc Neurosci. 2011;31(40):14250–63.
doi: 10.1523/JNEUROSCI.1835-11.2011
Ahmed MY, Chioza BA, Rajab A, Schmitz-Abe K, Al-Khayat A, Al-Turki S, et al. Loss of PCLO function underlies pontocerebellar hypoplasia type III. Neurology. 2015;84(17):1745–50.
pubmed: 25832664
pmcid: 4424132
doi: 10.1212/WNL.0000000000001523
McCullough J, Colf LA, Sundquist WI. Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem. 2013;82:663–92.
pubmed: 23527693
pmcid: 4047973
doi: 10.1146/annurev-biochem-072909-101058
McCullough J, Frost A, Sundquist WI. Structures, functions, and dynamics of ESCRT-III/Vps4 membrane remodeling and fission complexes. Annu Rev Cell Dev Biol. 2018;34:85–109.
pubmed: 30095293
pmcid: 6241870
doi: 10.1146/annurev-cellbio-100616-060600
Marin-Valencia I, Gerondopoulos A, Zaki MS, Ben-Omran T, Almureikhi M, Demir E, et al. Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia. Am J Hum Genet. 2017;101(3):441–50.
pubmed: 28823706
pmcid: 5590949
doi: 10.1016/j.ajhg.2017.07.015
Ivanova EL, Mau-Them FT, Riazuddin S, Kahrizi K, Laugel V, Schaefer E, et al. Homozygous truncating variants in TBC1D23 cause pontocerebellar hypoplasia and alter cortical development. Am J Hum Genet. 2017;101(3):428–40.
pubmed: 28823707
pmcid: 5590842
doi: 10.1016/j.ajhg.2017.07.010
Shin JJH, Gillingham AK, Begum F, Chadwick J, Munro S. TBC1D23 is a bridging factor for endosomal vesicle capture by golgins at the trans-Golgi. Nat Cell Biol. 2017;19(12):1424–32.
pubmed: 29084197
pmcid: 5712222
doi: 10.1038/ncb3627
Akizu N, Cantagrel V, Schroth J, Cai N, Vaux K, McCloskey D, et al. AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder. Cell. 2013;154(3):505–17.
pubmed: 23911318
doi: 10.1016/j.cell.2013.07.005
Kortüm F, Jamra RA, Alawi M, Berry SA, Borck G, Helbig KL, et al. Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9. Eur J Hum Genet. 2018;26(5):695–708.
pubmed: 29463858
pmcid: 5945775
doi: 10.1038/s41431-018-0098-2
Ferrandon S, DeVecchio J, Duraes L, Chouhan H, Karagkounis G, Davenport J, et al. CoA Synthase (COASY) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer. Cancer Res. 2020;80(2):334–46.
pubmed: 31704889
doi: 10.1158/0008-5472.CAN-19-1161
van Dijk T, Ferdinandusse S, Ruiter JPN, Alders M, Mathijssen IB, Parboosingh JS, et al. Biallelic loss of function variants in COASY cause prenatal onset pontocerebellar hypoplasia, microcephaly, and arthrogryposis. Eur J Hum Genet. 2018;26(12):1752–8.
pubmed: 30089828
pmcid: 6244412
doi: 10.1038/s41431-018-0233-0
Nguyen Trung M, Kieninger S, Fandi Z, Qiu D, Liu G, Mehendale NK, et al. Stable Isotopomers of myo-Inositol Uncover a Complex MINPP1-Dependent Inositol Phosphate Network. ACS Cent Sci. 2022;8(12):1683–94.
pubmed: 36589890
pmcid: 9801504
doi: 10.1021/acscentsci.2c01032
Ucuncu E, Rajamani K, Wilson MSC, Medina-Cano D, Altin N, David P, et al. MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia. Nat Commun. 2020;11(1):6087.
pubmed: 33257696
pmcid: 7705663
doi: 10.1038/s41467-020-19919-y
Coolen M, Altin N, Rajamani K, Pereira E, Siquier-Pernet K, Puig Lombardi E, et al. Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation. Am J Hum Genet. 2022;109(5):909–27.
pubmed: 35390279
pmcid: 9118116
doi: 10.1016/j.ajhg.2022.03.010
Whittaker DE, Oleari R, Gregory LC, Le Quesne-Stabej P, Williams HJ, Torpiano JG, et al. A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia. J Clin Invest. 2021;131(24):e141587.
pubmed: 34730112
pmcid: 8670848
doi: 10.1172/JCI141587
Sekulovski S, Trowitzsch S. What connects splicing of transfer RNA precursor molecules with pontocerebellar hypoplasia? BioEssays. 2023;45(2):e2200130.
pubmed: 36517085
doi: 10.1002/bies.202200130
Brun R. Zur Kenntnis der Bildungsfehler des Kleinhirns. Epikritische Bemerkungen zur Entwicklungspathologie, Morphologie und Klinik der Umschriebenen Entwicklungshemmungen des Neozerebellums. Schweiz Arch Neurol Psychiatr. 1917;1:48–105.
Bakker SP, Bouman KH. Atrophia olivo-pontocerebellaris. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1924;89(1):213–46.
Brouwer B. Hypoplasia ponto-neocerebellaris. Psychiatr Neurol (Amsterdam). 1924;6:461–9.
Krause F. Über einen Bildungsfehler des Kleinhirns und einige faseranatomische Beziehungen des Organs. Zeitschrift für die gesamte Neurol und Psychiatr. 1929;119:788–815.
doi: 10.1007/BF02863836
Rong T, Yao R, Deng Y, Lin Q, Wang G, Wang J, et al. Case report: a relatively mild phenotype produced by novel mutations in the SEPSECS gene. Front Pediatr. 2021;9:805575. Switzerland.
pubmed: 35155316
doi: 10.3389/fped.2021.805575
Iwama K, Sasaki M, Hirabayashi S, Ohba C, Iwabuchi E, Miyatake S, et al. Milder progressive cerebellar atrophy caused by biallelic SEPSECS mutations. J Hum Genet. 2016;61(6):527–31.
pubmed: 26888482
doi: 10.1038/jhg.2016.9
Mu W, Heller T, Barañano KW. Two siblings with a novel variant of EXOSC3 extended phenotypic spectrum of pontocerebellar hypoplasia 1B to an exceptionally mild form. BMJ Case Rep. 2021;14(1):e236732.
pubmed: 33462000
pmcid: 7813329
doi: 10.1136/bcr-2020-236732
Wu ZF, Lv KL, Yao SQ, Li Z, Cheng W, Zhang S, et al. Clinical and genetic characterization of a Chinese family with pontocerebellar hypoplasia type 7. Am J Med Genet Part A. 2023.
Marsh APL, Lukic V, Pope K, Bromhead C, Tankard R, Ryan MM, et al. Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss. Neurol Genet. 2015;1(2): e16.
pubmed: 27066553
pmcid: 4807911
doi: 10.1212/NXG.0000000000000014
Accogli A, Addour-Boudrahem N, Srour M. Diagnostic approach to cerebellar hypoplasia. Cerebellum. 2021;20(4):631–58.
pubmed: 33534089
doi: 10.1007/s12311-020-01224-5
Rüsch CT, Bölsterli BK, Kottke R, Steinfeld R, Boltshauser E. Pontocerebellar hypoplasia: a pattern recognition approach. Cerebellum. 2020;19(4):569–82.
pubmed: 32410094
doi: 10.1007/s12311-020-01135-5